The independent source for health policy research, polling, and news.
9,981-10,000 of 113,033 results
The Republican-controlled legislature passed a law barring patient visitation bans, a "signature accomplishment," says the St. Louis Post-Dispatch. But estimates of the cost of the law may have been low by a factor of 10, new analysis suggests. Paying for gowns, gloves, and masks is to blame.
A preliminary injunction had been sought by transgender people in Florida impacted by the state's ban on funding for gender-affirming care for all ages. It was denied. Medicaid loophole problems in Texas, approval for Medicaid expansion in South Dakota, and more are also in the news.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
But questions linger about whether the cost is worth it for drugs such as Wegovy and its cousin Ozempic, which has been called a "Hollywood drug.” Plus, other updates on physical fitness, stress eating, and Noom.
Reports of supply shortages of Adderall have been circulating for weeks, but the FDA now admits there is a problem and said it would work to keep supply available for patients. Also: a Moderna skin cancer vaccine, racial bias in spirometry tests, and more.
Becker's Hospital Review reports on survey results from over 500 medical groups, which show 89% say the overall regulatory burden on their businesses has gone up over the past year. Other news concerns Crozer Health, Laguna Honda nursing home, a donation to MGH and more.
The funds come from the passage of the American Rescue Plan Act. In other news, the federal government has reached a deal with victims of a doctor who sexually assaulted Native American boys for decades at federal hospitals in Montana and South Dakota.
Republican Attorney General Todd Rokita had requested the ban be allowed to take effect, but the state Supreme Court issued an order denying that request. Abortions can now take place at least until a court decision over the ban's constitutionality is made.
NBC News covers a study that found some babies in covid-related lockdowns took longer to reach certain developmental milestones than babies born pre-pandemic. Bloomberg, meanwhile, notes that the newest covid variants, such as the so-called XBB, may represent a threat.
Pfizer's bivalent booster shot has been authorized for children as young as 5, while Moderna's was authorized for 6 and up. Meanwhile, Novavax reports that booster doses of its covid vaccine seem to work against omicron BA.1, BA.2, and BA.5.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these various public health topics.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
Read recent commentaries about drug-cost issues.
The AP says the $150 million hospital merger between LCMC Health and three Tulane hospitals is going to mean "big changes" in the area, leaving just two big players on the hospital care scene. Also: worries over outsourcing of care; congenital syphilis; Medicaid changes in California; and more.
The CEO of the American Cancer Society says a recent study that suggested colonoscopies were less helpful than believed was "wildly misinterpreted." USA Today reported that gastroenterologists haven't changed their minds on the benefits of colonoscopies.
The U.S. Preventive Services Task Force also said children 12 and older should be screened for depression. Recently, the task force also said adults under 65 should be screened.
Researchers found that people who took an older class of diabetes drugs known as glitazones, or TZDs, had a 22% lower risk of developing dementia. A surprise $50,000 medical bill for asthma meds, Walmart entering the clinical trial recruitment market, and more are also in the news.
The insurtech company says it will only operate in Florida and California in order to reduce costs and settle medical liabilities.
Florida's surgeon general stirred up controversy by warning of cardiac risks for men who get covid shots, and has now faced what Politico calls "major blowback" from medical experts. Meanwhile, the White House is urging Americans to get updated boosters by Halloween.
© 2026 KFF